Synevo Medical Laboratory has modernized its laboratory in Dnipro, increasing its capacity by 20%.
According to the press release of Synevo, within the framework of modernization in the laboratory a diagnostic platform Cobas Pure from Roche Diagnostics (Switzerland) was installed, which is capable of performing 230 types of biochemical analyses at a rate of up to 870 tests per hour.
As a result of the upgrade, the total throughput capacity of bio/immunoassay analyzers in Dnipro will be 5,270 tests per hour.
“The capacity of the laboratory allows to qualitatively and quickly meet the demand of customers from the eastern and central regions of the country. Today this is a super-important task, as the work of the Synevo laboratory in Kharkov was suspended for security reasons, which significantly increased the load on the Dnipro laboratory of the company,” the press release emphasizes.
In general, thanks to the expansion of the analyzer base, the laboratory of Synevo in Dnipro can now perform 20% more tests of biochemical group (e.g. liver tests, kidney tests and others), electrolytes, as well as immunochemical group (e.g. thyroid hormones, reproductive panel, prenatal diagnostics, etc.).
“Synevo Ukraine” (Synevo Ukraine) is the largest network in Ukraine with 317 laboratory centers, seven laboratories (in Kiev, Lviv, Chernivtsi, Vinnitsa, Odessa, Kherson and Dnipro) and more than 1800 employees in 13 countries. The capacity of the network is more than 800 types of testing, annually serving about 4 million customers, performing more than 15.8 million tests. It is part of Medicover, a leading international healthcare and diagnostic services company.
Synevo International Laboratory Network (Synevo) is present in 10 European countries, with laboratories in Germany, Poland, Romania, Turkey, Georgia, Moldova, Bulgaria, Serbia, Bosnia and Herzegovina.
In 2017, Synevo Ukraine as part of Medicover was listed on Nasdaq (Stockholm), becoming the first and only medical company in Ukraine to carry out an IPO.
